Last reviewed · How we verify
Adjuvanted seasonal influenza vaccine
Adjuvanted seasonal influenza vaccine is a Biologic drug developed by Novartis Vaccines. It is currently in Phase 3 development.
At a glance
| Generic name | Adjuvanted seasonal influenza vaccine |
|---|---|
| Sponsor | Novartis Vaccines |
| Modality | Biologic |
| Phase | Phase 3 |
Approved indications
Common side effects
- Injection site pain
- Fatigue
- Headache
- Myalgia
- Arthralgia
- Gastrointestinal disorder
- Chills
- Pyrexia
- Injection site swelling
- Influenza like illness
- Sinusitis
- Nasopharyngitis
Key clinical trials
- A Study of Modified mRNA Vaccines in Healthy Adults (PHASE1)
- WU 345: Immune Responses to Adjuvanted and Non-adjuvanted Seasonal Influenza Vaccines in the Lymphoid Tissues. (EARLY_PHASE1)
- A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Adults (PHASE2)
- Safety and Immunogenicity First-in-human Dose-ranging Study of Self-Amplifying RNA Seasonal Influenza Vaccine in Adults (PHASE1)
- B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults (PHASE4)
- Effects of Aging on Primary and Secondary Vaccine Responses (PHASE1)
- A Study of An Adjuvanted Inactivated H7N9 Influenza Vaccine (PHASE2)
- A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19 (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Adjuvanted seasonal influenza vaccine CI brief — competitive landscape report
- Adjuvanted seasonal influenza vaccine updates RSS · CI watch RSS
- Novartis Vaccines portfolio CI
Frequently asked questions about Adjuvanted seasonal influenza vaccine
What is Adjuvanted seasonal influenza vaccine?
Adjuvanted seasonal influenza vaccine is a Biologic drug developed by Novartis Vaccines.
Who makes Adjuvanted seasonal influenza vaccine?
Adjuvanted seasonal influenza vaccine is developed by Novartis Vaccines (see full Novartis Vaccines pipeline at /company/novartis-vaccines).
What development phase is Adjuvanted seasonal influenza vaccine in?
Adjuvanted seasonal influenza vaccine is in Phase 3.
What are the side effects of Adjuvanted seasonal influenza vaccine?
Common side effects of Adjuvanted seasonal influenza vaccine include Injection site pain, Fatigue, Headache, Myalgia, Arthralgia, Gastrointestinal disorder.